Israeli AI Biotech Immunai Teams Up with Bristol Myers Squibb to Advance Drug Development
Israeli AI Biotech Immunai partners with Bristol Myers Squibb, utilizing its AMICA-OS platform to accelerate drug development. This collaboration promises to.
Israeli AI Biotech Immunai partners with Bristol Myers Squibb, utilizing its AMICA-OS platform to accelerate drug development. This collaboration promises to.
Tel Aviv's CytoReason launches LINA AI assistant for drug development at JP Morgan Healthcare Conference, speeding research with accurate, biology-grounded.